<i>T+31C</i> Polymorphism of Angiotensinogen Gene and Essential Hypertension

Kazuhiko Ishikawa(National Cerebral and Cardiovascular Center), Toshio Ogihara(Osaka University), Jun Ogata(Keio University), Shin Takiuchi(Sakurabashi Watanabe Hospital), Masayuki Fukuda(University of Medicine Tirana), Takashi Asai(Dokkyo Medical University), Yuxiao Fu(University of Medicine Tirana), Naoharu Iwai(National Cerebral and Cardiovascular Center), Shunroku Baba(National Cerebral and Cardiovascular Center), Toshifumi Mannami(National Cerebral and Cardiovascular Center), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Tomohiro Katsuya(Japan Medical Association)
Hypertension
February 1, 2001
10.1161/01.hyp.37.2.281
Cited by 42

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485
Meta-analysis identifies common variants associated with body mass index in east Asians
|Nature Genetics|2012|405